Cargando…

Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies

Surgical resection is the cornerstone of solid tumour treatment. Current techniques for evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative ultrasound, are helpful. However, an intraoperative assessment of tumour margins that is accurate and safe is clinically ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortot, Barbara, Mangogna, Alessandro, Di Lorenzo, Giovanni, Stabile, Guglielmo, Ricci, Giuseppe, Biffi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193783/
https://www.ncbi.nlm.nih.gov/pubmed/37202750
http://dx.doi.org/10.1186/s12951-023-01926-y
_version_ 1785043887348252672
author Bortot, Barbara
Mangogna, Alessandro
Di Lorenzo, Giovanni
Stabile, Guglielmo
Ricci, Giuseppe
Biffi, Stefania
author_facet Bortot, Barbara
Mangogna, Alessandro
Di Lorenzo, Giovanni
Stabile, Guglielmo
Ricci, Giuseppe
Biffi, Stefania
author_sort Bortot, Barbara
collection PubMed
description Surgical resection is the cornerstone of solid tumour treatment. Current techniques for evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative ultrasound, are helpful. However, an intraoperative assessment of tumour margins that is accurate and safe is clinically necessary. Positive surgical margins (PSM) have a well-documented negative effect on treatment outcomes and survival. As a result, surgical tumour imaging methods are now a practical method for reducing PSM rates and improving the efficiency of debulking surgery. Because of their unique characteristics, nanoparticles can function as contrast agents in image-guided surgery. While most image-guided surgical applications utilizing nanotechnology are now in the preclinical stage, some are beginning to reach the clinical phase. Here, we list the various imaging techniques used in image-guided surgery, such as optical imaging, ultrasound, computed tomography, magnetic resonance imaging, nuclear medicine imaging, and the most current developments in the potential of nanotechnology to detect surgical malignancies. In the coming years, we will see the evolution of nanoparticles tailored to specific tumour types and the introduction of surgical equipment to improve resection accuracy. Although the promise of nanotechnology for producing exogenous molecular contrast agents has been clearly demonstrated, much work remains to be done to put it into practice. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10193783
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101937832023-05-19 Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies Bortot, Barbara Mangogna, Alessandro Di Lorenzo, Giovanni Stabile, Guglielmo Ricci, Giuseppe Biffi, Stefania J Nanobiotechnology Review Surgical resection is the cornerstone of solid tumour treatment. Current techniques for evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative ultrasound, are helpful. However, an intraoperative assessment of tumour margins that is accurate and safe is clinically necessary. Positive surgical margins (PSM) have a well-documented negative effect on treatment outcomes and survival. As a result, surgical tumour imaging methods are now a practical method for reducing PSM rates and improving the efficiency of debulking surgery. Because of their unique characteristics, nanoparticles can function as contrast agents in image-guided surgery. While most image-guided surgical applications utilizing nanotechnology are now in the preclinical stage, some are beginning to reach the clinical phase. Here, we list the various imaging techniques used in image-guided surgery, such as optical imaging, ultrasound, computed tomography, magnetic resonance imaging, nuclear medicine imaging, and the most current developments in the potential of nanotechnology to detect surgical malignancies. In the coming years, we will see the evolution of nanoparticles tailored to specific tumour types and the introduction of surgical equipment to improve resection accuracy. Although the promise of nanotechnology for producing exogenous molecular contrast agents has been clearly demonstrated, much work remains to be done to put it into practice. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-05-18 /pmc/articles/PMC10193783/ /pubmed/37202750 http://dx.doi.org/10.1186/s12951-023-01926-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Bortot, Barbara
Mangogna, Alessandro
Di Lorenzo, Giovanni
Stabile, Guglielmo
Ricci, Giuseppe
Biffi, Stefania
Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
title Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
title_full Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
title_fullStr Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
title_full_unstemmed Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
title_short Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
title_sort image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193783/
https://www.ncbi.nlm.nih.gov/pubmed/37202750
http://dx.doi.org/10.1186/s12951-023-01926-y
work_keys_str_mv AT bortotbarbara imageguidedcancersurgeryanarrativereviewonimagingmodalitiesandemergingnanotechnologystrategies
AT mangognaalessandro imageguidedcancersurgeryanarrativereviewonimagingmodalitiesandemergingnanotechnologystrategies
AT dilorenzogiovanni imageguidedcancersurgeryanarrativereviewonimagingmodalitiesandemergingnanotechnologystrategies
AT stabileguglielmo imageguidedcancersurgeryanarrativereviewonimagingmodalitiesandemergingnanotechnologystrategies
AT riccigiuseppe imageguidedcancersurgeryanarrativereviewonimagingmodalitiesandemergingnanotechnologystrategies
AT biffistefania imageguidedcancersurgeryanarrativereviewonimagingmodalitiesandemergingnanotechnologystrategies